Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Trainor

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Quinazolines as cyclin dependent kinase inhibitorsT M Sielecki, T L Johnson, J Liu, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
The Journal of Biological Chemistry|August 12, 2000
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesisR A Copeland, J Marcinkeviciene, T S Haque, et al.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Identification of selective inhibitors of cyclin dependent kinase 4D J Carini, R F Kaltenbach, J Liu, et al.
Leukemia|October 22, 2011
Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2A V Purandare, T M McDevitt, H Wan, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization productsJ V Duncia, J B Santella, C A Higley, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Quinazolines as cyclin dependent kinase inhibitorsT M Sielecki, T L Johnson, J Liu, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1J W Corbett, S S Ko, J D Rodgers, et al.
The Journal of Biological Chemistry|August 12, 2000
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesisR A Copeland, J Marcinkeviciene, T S Haque, et al.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Identification of selective inhibitors of cyclin dependent kinase 4D J Carini, R F Kaltenbach, J Liu, et al.
Leukemia|October 22, 2011
Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2A V Purandare, T M McDevitt, H Wan, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization productsJ V Duncia, J B Santella, C A Higley, et al.
Pageof 3